| HGNC Family | G protein-coupled receptors |
| Name | olfactory receptor, family 4, subfamily C, member 13 |
| Description | Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\niPLA2γ is a multifunctional calcium‐independent phospholipase that plays a central role in mitochondrial lipid homeostasis. It tailors the composition of mitochondrial membranes—most notably cardiolipin—thereby preserving efficient electron transport and oxidative phosphorylation. Genetic ablation studies reveal that loss of iPLA2γ impairs complex IV activity, reduces mitochondrial respiration, alters cardiolipin molecular species, and induces mitochondrial degeneration accompanied by autophagy. Moreover, iPLA2γ is critical for the hydrolysis of oxidized fatty acids released during oxidative stress, modulating mitochondrial uncoupling via UCP2 and influencing the opening of the mitochondrial permeability transition pore."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "6"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn adipose and pancreatic tissues, iPLA2γ proves indispensable for proper differentiation and function. During hormone‐induced adipogenesis, its expression is markedly upregulated and is required for driving the expression of adipogenic transcription factors such as PPARγ and C/EBPα. Furthermore, in pancreatic beta cells, iPLA2γ activity facilitates the release of arachidonic acid, a critical mediator of glucose‐stimulated insulin secretion. Inhibition or knockdown of iPLA2γ impairs these processes, underscoring its role in metabolic regulation."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "7", "end_ref": "9"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn the liver, the phospholipase activity of iPLA2γ (also referred to as PNPLA8) links membrane phospholipid catabolism to broader metabolic pathways. By converting phosphatidylcholine into glycerophosphocholine, iPLA2γ supports methyl group metabolism and modulates triglyceride synthesis. This activity appears to promote autophagic flux that counters hepatic steatosis, thereby contributing to the maintenance of lipid homeostasis and metabolic balance."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn the kidney, particularly within glomerular epithelial cells (podocytes), iPLA2γ serves a cytoprotective role. Although its deletion triggers mitochondrial damage, energy dysregulation, and enhanced autophagy, studies in models of glomerular injury and diabetic nephropathy indicate that the absence of iPLA2γ can also confer protection against progressive albuminuria and glomerular sclerosis. This suggests that, in renal tissue, iPLA2γ’s function is complex and context dependent, balancing between maintenance of mitochondrial integrity and modulation of stress‐induced autophagy."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "12"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "David J Mancuso, Harold F Sims, Xianlin Han, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic ablation of calcium-independent phospholipase A2gamma leads to alterations in mitochondrial lipid metabolism and function resulting in a deficient mitochondrial bioenergetic phenotype."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M707795200"}], "href": "https://doi.org/10.1074/jbc.M707795200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17923475"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17923475"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "David J Mancuso, Paul Kotzbauer, David F Wozniak, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic ablation of calcium-independent phospholipase A2{gamma} leads to alterations in hippocampal cardiolipin content and molecular species distribution, mitochondrial degeneration, autophagy, and cognitive dysfunction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M109.055194"}], "href": "https://doi.org/10.1074/jbc.M109.055194"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19840936"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19840936"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Gao-Yuan Liu, Sung Ho Moon, Christopher M Jenkins, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The phospholipase iPLA"}, {"type": "a", "children": [{"type": "t", "text": "sub"}], "href": "sub"}, {"type": "t", "text": "2"}, {"type": "a", "children": [{"type": "t", "text": "/sub"}], "href": "/sub"}, {"type": "t", "text": "γ is a major mediator releasing oxidized aliphatic chains from cardiolipin, integrating mitochondrial bioenergetics and signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M117.783068"}], "href": "https://doi.org/10.1074/jbc.M117.783068"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28442572"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28442572"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Emiko Yoda, Keiko Hachisu, Yoshitaka Taketomi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mitochondrial dysfunction and reduced prostaglandin synthesis in skeletal muscle of Group VIB Ca2+-independent phospholipase A2gamma-deficient mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Lipid Res (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1194/jlr.M008060"}], "href": "https://doi.org/10.1194/jlr.M008060"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20625036"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20625036"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Martin Jabůrek, Jan Ježek, Jaroslav Zelenka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Antioxidant activity by a synergy of redox-sensitive mitochondrial phospholipase A2 and uncoupling protein-2 in lung and spleen."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Biochem Cell Biol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biocel.2013.01.010"}], "href": "https://doi.org/10.1016/j.biocel.2013.01.010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23354121"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23354121"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Sung Ho Moon, David J Mancuso, Harold F Sims, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cardiac Myocyte-specific Knock-out of Calcium-independent Phospholipase A2γ (iPLA2γ) Decreases Oxidized Fatty Acids during Ischemia/Reperfusion and Reduces Infarct Size."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M116.740597"}], "href": "https://doi.org/10.1074/jbc.M116.740597"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27453526"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27453526"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Xiong Su, David J Mancuso, Perry E Bickel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Small interfering RNA knockdown of calcium-independent phospholipases A2 beta or gamma inhibits the hormone-induced differentiation of 3T3-L1 preadipocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M314166200"}], "href": "https://doi.org/10.1074/jbc.M314166200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15024020"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15024020"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Keying Song, Xu Zhang, Chunying Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of Ca2+-independent phospholipase A2 results in insufficient insulin secretion and impaired glucose tolerance."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Endocrinol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/me.2004-0169"}], "href": "https://doi.org/10.1210/me.2004-0169"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15471944"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15471944"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Emiko Yoda, Keiko Hachisu, Hiroshi Kuwata, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Gene Deletion of Calcium-Independent Phospholipase A"}, {"type": "a", "children": [{"type": "t", "text": "sub"}], "href": "sub"}, {"type": "t", "text": "2"}, {"type": "a", "children": [{"type": "t", "text": "/sub"}], "href": "/sub"}, {"type": "t", "text": "γ (iPLA"}, {"type": "a", "children": [{"type": "t", "text": "sub"}], "href": "sub"}, {"type": "t", "text": "2"}, {"type": "a", "children": [{"type": "t", "text": "/sub"}], "href": "/sub"}, {"type": "t", "text": "γ) Suppresses Adipogenic Differentiation of Mouse Embryonic Fibroblasts."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biol Pharm Bull (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1248/bpb.b20-00321"}], "href": "https://doi.org/10.1248/bpb.b20-00321"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32879212"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32879212"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Kwang-Youn Kim, Hyun-Jun Jang, Yong Ryoul Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SREBP-2/PNPLA8 axis improves non-alcoholic fatty liver disease through activation of autophagy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep35732"}], "href": "https://doi.org/10.1038/srep35732"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27767079"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27767079"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Tetsuya Hirabayashi, Mai Kawaguchi, Sayaka Harada, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hepatic phosphatidylcholine catabolism driven by PNPLA7 and PNPLA8 supplies endogenous choline to replenish the methionine cycle with methyl groups."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Rep (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.celrep.2022.111940"}], "href": "https://doi.org/10.1016/j.celrep.2022.111940"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36719796"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36719796"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Hanan Elimam, Joan Papillon, Julie Guillemette, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic Ablation of Calcium-independent Phospholipase A"}, {"type": "a", "children": [{"type": "t", "text": "sub"}], "href": "sub"}, {"type": "t", "text": "2"}, {"type": "a", "children": [{"type": "t", "text": "/sub"}], "href": "/sub"}, {"type": "t", "text": "γ Exacerbates Glomerular Injury in Adriamycin Nephrosis in Mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-019-52834-x"}], "href": "https://doi.org/10.1038/s41598-019-52834-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31700134"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31700134"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Andrey V Cybulsky, Joan Papillon, Julie Guillemette, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic deletion of calcium-independent phospholipase A2γ protects mice from diabetic nephropathy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0311404"}], "href": "https://doi.org/10.1371/journal.pone.0311404"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "39480824"}], "href": "https://pubmed.ncbi.nlm.nih.gov/39480824"}]}]}]}
|
| Proteins | OR4CD_HUMAN |
| NCBI Gene ID | 283092 |
| API | |
| Download Associations | |
| Predicted Functions |
 |
| Co-expressed Genes |
|
| Expression in Tissues and Cell Lines |
|
OR4C13 has 733 functional associations with biological entities spanning 7 categories (molecular profile, functional term, phrase or reference, disease, phenotype or trait, chemical, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 47 datasets.
Click the + buttons to view associations for OR4C13 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of OR4C13 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of OR4C13 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of OR4C13 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of OR4C13 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of OR4C13 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of OR4C13 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of OR4C13 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing OR4C13 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with OR4C13 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of OR4C13 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with OR4C13 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Disease Associations | diseases associated with OR4C13 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by OR4C13 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with OR4C13 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with OR4C13 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at OR4C13 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of OR4C13 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of OR4C13 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing OR4C13 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing OR4C13 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of OR4C13 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of OR4C13 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of OR4C13 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving OR4C13 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing OR4C13 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by OR4C13 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by OR4C13 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of OR4C13 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with OR4C13 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of OR4C13 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for OR4C13 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of OR4C13 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of OR4C13 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways 2026 | pathways involving OR4C13 protein from the KEGG Pathways 2026 dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of OR4C13 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of OR4C13 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain OR4C13 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of OR4C13 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Reactome Pathways 2014 | pathways involving OR4C13 protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving OR4C13 protein from the Reactome Pathways 2024 dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at OR4C13 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of OR4C13 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of OR4C13 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of OR4C13 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of OR4C13 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of OR4C13 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with OR4C13 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
